SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-17-228636
Filing Date
2017-07-14
Accepted
2017-07-14 17:16:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d419868ds1.htm S-1 596255
2 EXHIBIT 5.1 d419868dex51.htm EX-5.1 5189
3 EXHIBIT 23.1 d419868dex231.htm EX-23.1 1606
4 GRAPHIC g419868g09q97.gif GRAPHIC 3087
5 GRAPHIC g419868g22s61.gif GRAPHIC 4625
6 GRAPHIC g419868g71a27.jpg GRAPHIC 34280
7 GRAPHIC g419868g81p64.jpg GRAPHIC 137895
8 GRAPHIC g419868g81r24.jpg GRAPHIC 31756
  Complete submission text file 0001193125-17-228636.txt   896207
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-219300 | Film No.: 17966102
SIC: 2834 Pharmaceutical Preparations